Ixempra 15 Mg

Having the support of our expert team has enabled us to export and supply a quality range of Ixempra 15 Mg. Basically, the proposed range comprises of Ixabepilone which act as an epothilone B that act as anti cancer drugs. Approved by FDA, this range is widely accepted for treating aggressive metastatic or locally advanced breast cancer that can no longer be treated with currently available chemotherapies.  Moreover, Ixempra 15 Mg is highly recommended in cancer related to breast, head, neck, melanoma, lung, lymphoma, prostate and renal cell carcinoma.

Benefits:

• Precise composition
• Safe to use
• Long shelf life